Exogenous surfactant in acute respiratory distress syndrome: More is better

European Respiratory Journal

Volumn 19, Issue 5, 2002, Pages 787-789

  Anzueto, A ^a  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPROTEIN; ARTIFICIAL LUNG SURFACTANT; CARBOHYDRATE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE; PHOSPHOLIPID; PLACEBO; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ACUTE DISEASE; AEROSOL; BRONCHOSCOPE; CHEMICAL COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG INSTILLATION; EDITORIAL; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS SURFACE TENSION; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG INJURY; LUNG MECHANICS; OXYGENATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEPTIC SHOCK; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; BRONCHOSCOPY; LUNG; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NOTE; TREATMENT OUTCOME;

ADULT; BRONCHOSCOPY; HUMAN; INFANT, NEWBORN; LUNG; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME; HUMANS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0036014509     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00284902     Document Type: Editorial

References (24)

1. Surface active materials from dog lung: Composition and physiological correlations
2. Recycling of surfactant in black and beige mice: Pool sizes and kinetics
3. Evidence of lung surfactant abnormality in respiratory failure: Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol
4. State of the art: Surfactant for the treatment of respiratory distress syndrome
5. Acute respiratory distress in adults
6. Surfactant and the adult respiratory distress syndrome
7. Surface properties in relation to atelectasis and hyaline membrane disease
8. Characteristics of pulmonary surfactant in adult respiratory syndrome associated with trauma and shock
9. Abnormalities in lung properties and surfactant function in adult respiratory distress syndrome
10. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
11. Alterations in alveolar surfactant following severe multiple trauma
12. Alteration of surfactant fatty acid profile in acute inflammatory and chronic interstitial lung disease
13. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity
14. Inhibition of pulmonary surfactant function by phospholipases
15. Interaction of surfacant mixtures with reactive oxygen and nitrogen species
16. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters tension properties
17. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome
18. A multi centered trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (Exosurf)
19. Bovine surfactant therapy for patients with acute respiratory distress syndrome
20. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
21. Efficiency of the delivery of aerosolized artificial surfactant in intubated patients with the adult respiratory distress syndrome
22. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: Impact on biophysical and biochemical surfactant properties
23. 4-surfactant) for acute respiratory distress syndrome
24. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: Impact on gas exchange and haemodynamics